Combining radiotherapy with MEK1/2, STAT5 or STAT6 inhibition reduces survival of head and neck cancer lines-Reference-Cited by-同舟云学术

Combining radiotherapy with MEK1/2, STAT5 or STAT6 inhibition reduces survival of head and neck cancer lines

Published:2013 Issue:1 Volume:12 Page:133
ISSN:1476-4598
Container-title:Molecular Cancer
language:en
Short-container-title:Molecular Cancer

Author:

Stegeman Hanneke,Kaanders Johannes HAM,Verheijen Marieke MG,Peeters Wenny JM,Wheeler Deric L,Iida Mari,Grénman Reidar,van der Kogel Albert J,Span Paul N,Bussink Johan

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Molecular Medicine

Reference32 articles.

1. Chemoradiation for upper aerodigestive tract cancer: balancing evidence from clinical trials with individual patient recommendations

2. Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck

3. Mechanisms of acquired resistance to cetuximab: role of HER (ErbB) family members

4. A Two-in-One Antibody against HER3 and EGFR Has Superior Inhibitory Activity Compared with Monospecific Antibodies

5. Dual Blockade of EGFR and c-Met Abrogates Redundant Signaling and Proliferation in Head and Neck Carcinoma Cells

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of tumor stemness and immunity related prognostic factors and sensitive drugs in head and neck squamous cell carcinoma;Scientific Reports;2024-07-10

2. Expression of genes potentially involved in loss of response in patients with chronic myeloid leukemia;Gene;2024-02

3. Advantages of the Combinatorial Molecular Targeted Therapy of Head and Neck Cancer—A Step before Anakoinosis-Based Personalized Treatment;Cancers;2023-08-24

4. The Role of STATs in Ovarian Cancer: Exploring Their Potential for Therapy;Cancers;2023-04-26

5. Current and Emerging Molecular Therapies for Head and Neck Squamous Cell Carcinoma;Cancers;2021-10-30